New
HealthMore in Health→
Prime Editing May Give Cell Therapies a Drug-Controlled Dial
Key Takeaways
- WEHI-led researchers reported a prime-editing platform in Blood.
- The approach is designed to make therapeutic T cells resistant to a commonly used immunosuppressive drug.
- The work is preclinical research and not an established patient treatment.
DE
DT Editorial Team··via medicalxpress.com